Meningiomas are the most frequent primary intracranial tumours in adults, exhibiting a spectrum from benign to highly aggressive phenotypes. Diagnosis typically begins with neuroimaging, principally ...

WASHINGTON, September 29, 2024 — A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering ...

Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College ...

DelveInsight's,“ Meningioma Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Meningioma pipeline landscape. It covers the Meningioma pipeline ...

Meningiomas are usually noncancerous tumors that grow slowly in the brain. Symptoms like headaches or seizures may indicate a larger meningioma pressing on brain tissue. If you have meningioma ...

ROCHESTER, Minn.--(BUSINESS WIRE)-- Meningiomas, the most common type of brain tumors, are rarely cancerous and may not require treatment. The July issue of Mayo Clinic Health Letter offers an ...

Researchers at Baylor College of Medicine and Washington University School of Medicine in St. Louis have identified clinical and genetic predictors of multiply recurrent meningiomas (MRMs), a most ...

Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01. Background: Patients with ...

A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors. Background: Meningiomas, the most frequent primary ...

Integrating multiple molecular profiling approaches of meningioma, the most common primary brain tumor, could transform patient care by providing a better prognosis and revealing the tumors that ...